Cavendish Impact Capital manages a suite of Impact Capital Funds designed to allocate critical capital resources.
Cavendish Impact Capital manage a suite of Impact Capital Funds designed to allocate critical capital resources to confront and combat some of humankind’s most pressing global challenges. The initial fund in the suite, The Cavendish Impact Capital Life Science Fund, will provide vital capital and a path to the marketplace for early-stage health and life science companies whose innovations have the potential to provide a transformational impact on disease prevention, diagnosis or treatment.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Nov 3, 2020
Massive Bio
|
Seed | $2.81M | Artificial Intelligence | — |